Apricus Biosciences, Inc. Formerly Nexmed Inc.
Apricus Biosciences, Inc. is listed today as Apricus Biosciences : market value, financials and filings are on its company page.
Funding rounds 2 counted as startup funding. Open the number of investors for the round's details.
Funding rounds of Apricus Biosciences, Inc. Month Raised Raise Size Investors Sold Filing Sep 2017 $4 M No. 2 $2 to $10 million 9
Apricus Biosciences, Inc.: Raise no. 2, Sep 2017 × Investors in this round 9 investors had bought by the notice of Sep 27, 2017: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $258,370
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Nevada People named in the notice Brian D. Dorsey · Executive Officer Neil D. Morton · Executive Officer Richard W. Pascoe · Executive Officer, Director Kleanthis G. Xanthopoulos · Director Paul V. Maier · Director Rusty W. Ray · Director Sandford D. Smith · Director Wendell W. Wierenga · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. WAINWRIGHT & CO., LLC (CRD 375) · New York, New York Sold in NY Signed by Richard W. Pascoe, Chief Executive Officer and Secretary. Newest notice filed Sep 27, 2017. Read the notice at the SEC .
equity, options SEC Sep 2016 $4 M No. 1 $2 to $10 million 2
Apricus Biosciences, Inc.: Raise no. 1, Sep 2016 × Investors in this round 2 investors had bought by the notice of Oct 13, 2016: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $327,548
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Nevada People named in the notice Brian D. Dorsey · Executive Officer Catherine D. Bovenizer · Executive Officer Neil D. Morton · Executive Officer Richard W. Pascoe · Executive Officer, Director Kleanthis G. Xanthopoulos · Director Paul V. Maier · Director Rusty W. Ray · Director Sandford D. Smith · Director Wendell W. Wierenga · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round RODMAN & RENSHAW LLC (CRD 281264) · New York, New York Sold in FL, IL Signed by Richard W. Pascoe, Chief Executive Officer and Secretary. Newest notice filed Oct 13, 2016. Read the notice at the SEC .
options SEC
What its filings and its own website say, sentence by sentence, each with its source.
Apricus Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2017).
SEC Form D · Sep 2017
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Sep 2017
No products or services of Apricus Biosciences, Inc. are on record.
No investor of Apricus Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Apricus Biosciences, Inc. Name Role Named in Brian D. Dorsey Executive officer Sep 2017 Neil D. Morton Executive officer Sep 2017 Richard W. Pascoe Executive officer Sep 2017 Catherine D. Bovenizer Executive officer Oct 2016 Kleanthis G. Xanthopoulos Director Sep 2017 Paul V. Maier Director Sep 2017 Richard W. Pascoe Director Sep 2017 Rusty W. Ray Director Sep 2017 Sandford D. Smith Director Sep 2017 Wendell W. Wierenga Director Sep 2017